ArticleThoracic cancer2026

Efficacy and Safety of Immune Checkpoint Inhibitors for Lung Cancer Complicated by Interstitial Pneumonia: The CS-Lung 003 Study, Branch Number 28.

Kosuke Hamai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.